ACHIEVE LIFE SCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.41 USD | 0.00% |
|
+8.20% | +31.31% |
| 05-13 | Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating | MT |
| 05-09 | Transcript : Achieve Life Sciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 186M | - | - | - | - | - | |
| 63.85B | - | |||||
| 41.83B | ||||||
| 40.65B | ||||||
| 27.12B | ||||||
| 26.52B |
